• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

社区获得性肺炎耐甲氧西林金黄色葡萄球菌和 感染的危险因素评估。

Risk Factor Evaluation for Methicillin-Resistant and in Community-Acquired Pneumonia.

机构信息

Johnson City Medical Center, Johnson City, TN, USA.

出版信息

Ann Pharmacother. 2021 Jan;55(1):36-43. doi: 10.1177/1060028020935106. Epub 2020 Jun 16.

DOI:10.1177/1060028020935106
PMID:32545992
Abstract

BACKGROUND

The 2019 community-acquired pneumonia guidelines recommend using recent respiratory cultures and locally validated epidemiology plus risk factor assessment to determine empirical coverage of methicillin-resistant (MRSA) and .

OBJECTIVE

To develop a methodology for evaluating local epidemiology and validating local risk factors for and MRSA.

METHODS

This multicenter, retrospective cohort evaluated adult patients admitted for pneumonia. Risk factors for MRSA and were evaluated using multivariable logistic regression and reported as adjusted odds ratios (aORs).

RESULTS

There were 10 723 cases evaluated. Lung abscess/empyema had the highest odds associated with MRSA (aOR = 4.24; < 0.0001), followed by influenza (aOR = 2.34; = 0.01), end-stage renal disease (ESRD; aOR = 2.09; = 0.006), illicit substance use (aOR = 1.7; = 0.007), and chronic obstructive pulmonary disease (COPD; aOR = 1.26; = 0.04). For aeruginosa, the highest odds were in bronchiectasis (aOR = 6.13; < 0.0001), lung abscess/empyema (aOR = 3.36; = 0.005), and COPD (aOR = 1.84; < 0.0001). Isolated COPD without other risk factors did not pose an increased risk of either organism.

CONCLUSION AND RELEVANCE

Influenza, ESRD, lung abscess/empyema, and illicit substance use were local risk factors for MRSA. Bronchiectasis and lung abscess/empyema were risk factors for . COPD was associated with MRSA and . However, isolated COPD had similar rates of MRSA and pneumonia compared with the total population. This study established a feasible methodology for evaluating local risk factors.

摘要

背景

2019 年社区获得性肺炎指南建议使用近期呼吸道培养和经过验证的本地流行病学数据以及危险因素评估,以确定耐甲氧西林金黄色葡萄球菌(MRSA)和 的经验性覆盖范围。

目的

开发一种评估本地流行病学和验证 和 MRSA 本地危险因素的方法。

方法

这项多中心回顾性队列研究评估了因肺炎住院的成年患者。使用多变量逻辑回归评估 MRSA 和 的危险因素,并报告为调整后的优势比(aOR)。

结果

共评估了 10723 例病例。肺脓肿/积脓与 MRSA 相关的可能性最高(aOR=4.24;<0.0001),其次是流感(aOR=2.34;=0.01)、终末期肾病(ESRD;aOR=2.09;=0.006)、非法药物使用(aOR=1.7;=0.007)和慢性阻塞性肺疾病(COPD;aOR=1.26;=0.04)。对于铜绿假单胞菌,支气管扩张症(aOR=6.13;<0.0001)、肺脓肿/积脓(aOR=3.36;=0.005)和 COPD(aOR=1.84;<0.0001)的可能性最高。没有其他危险因素的孤立性 COPD 并未增加这两种病原体的感染风险。

结论和相关性

流感、ESRD、肺脓肿/积脓和非法药物使用是 MRSA 的本地危险因素。支气管扩张症和肺脓肿/积脓是 的危险因素。然而,孤立性 COPD 与总体人群相比,MRSA 和 肺炎的发生率相似。本研究建立了一种可行的评估本地危险因素的方法。

相似文献

1
Risk Factor Evaluation for Methicillin-Resistant and in Community-Acquired Pneumonia.社区获得性肺炎耐甲氧西林金黄色葡萄球菌和 感染的危险因素评估。
Ann Pharmacother. 2021 Jan;55(1):36-43. doi: 10.1177/1060028020935106. Epub 2020 Jun 16.
2
Risk factors associated with potentially antibiotic-resistant pathogens in community-acquired pneumonia.社区获得性肺炎中与潜在抗生素耐药病原体相关的危险因素。
Ann Am Thorac Soc. 2015 Feb;12(2):153-60. doi: 10.1513/AnnalsATS.201407-305OC.
3
Health care-associated pneumonia (HCAP): empiric antibiotics targeting methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa predict optimal outcome.医疗保健相关肺炎(HCAP):针对耐甲氧西林金黄色葡萄球菌(MRSA)和铜绿假单胞菌的经验性抗生素治疗可预测最佳治疗结果。
Medicine (Baltimore). 2011 Nov;90(6):390-395. doi: 10.1097/MD.0b013e318239cf0a.
4
Variation in Empiric Coverage Versus Detection of Methicillin-Resistant Staphylococcus aureus and Pseudomonas aeruginosa in Hospitalizations for Community-Onset Pneumonia Across 128 US Veterans Affairs Medical Centers.美国128家退伍军人事务医疗中心社区获得性肺炎住院患者中,经验性抗菌覆盖范围与耐甲氧西林金黄色葡萄球菌和铜绿假单胞菌检测率的差异
Infect Control Hosp Epidemiol. 2017 Aug;38(8):937-944. doi: 10.1017/ice.2017.98. Epub 2017 Jun 21.
5
Incidence of drug-resistant pathogens in community-acquired pneumonia at a safety net hospital.安全网医院社区获得性肺炎中耐药病原体的发生率。
Microbiol Spectr. 2024 Aug 6;12(8):e0079224. doi: 10.1128/spectrum.00792-24. Epub 2024 Jul 16.
6
Prediction of methicillin-resistant Staphylococcus aureus in patients with non-nosocomial pneumonia.预测非医院获得性肺炎患者的耐甲氧西林金黄色葡萄球菌。
BMC Infect Dis. 2013 Aug 9;13:370. doi: 10.1186/1471-2334-13-370.
7
Predictors of Pseudomonas and methicillin-resistant Staphylococcus aureus in hospitalized patients with healthcare-associated pneumonia.医院获得性肺炎住院患者中铜绿假单胞菌和耐甲氧西林金黄色葡萄球菌的预测因素
Respirology. 2016 Jan;21(1):157-63. doi: 10.1111/resp.12651. Epub 2015 Oct 8.
8
Risk factors for drug-resistant pathogens in immunocompetent patients with pneumonia: Evaluation of PES pathogens.免疫功能正常的肺炎患者中耐药病原体的危险因素:PES病原体评估
J Infect Chemother. 2017 Jan;23(1):23-28. doi: 10.1016/j.jiac.2016.09.002. Epub 2016 Oct 8.
9
Proposed risk factors for infection with multidrug-resistant pathogens in hemodialysis patients hospitalized with pneumonia.因肺炎住院的血液透析患者感染多重耐药病原体的潜在风险因素。
BMC Infect Dis. 2017 Oct 12;17(1):681. doi: 10.1186/s12879-017-2788-8.
10
Rationale and design of ASPIRE-ICU: a prospective cohort study on the incidence and predictors of Staphylococcus aureus and Pseudomonas aeruginosa pneumonia in the ICU.ASPIRE-ICU研究的原理与设计:一项关于重症监护病房金黄色葡萄球菌和铜绿假单胞菌肺炎发病率及预测因素的前瞻性队列研究
BMC Infect Dis. 2017 Sep 25;17(1):643. doi: 10.1186/s12879-017-2739-4.

引用本文的文献

1
Weighing options: empiric antibiotic use and stewardship opportunities in critically ill patients with community-acquired pneumonia.权衡选择:社区获得性肺炎重症患者的经验性抗生素使用及管理机会
Antimicrob Steward Healthc Epidemiol. 2025 Aug 7;5(1):e180. doi: 10.1017/ash.2025.10082. eCollection 2025.
2
Risk factors for drug-resistant pathogens in community-acquired pneumonia: systematic review and meta-analysis.社区获得性肺炎中耐药病原体的危险因素:系统评价与荟萃分析
Eur Respir Rev. 2025 Mar 19;34(175). doi: 10.1183/16000617.0183-2024. Print 2025 Jan.
3
Impact of Antipseudomonal Antibiotics in Patients with Bronchiectasis Who Experienced Exacerbation or Developed Pneumonia: A Nationwide Study in Japan.
抗铜绿假单胞菌抗生素对支气管扩张症急性加重或并发肺炎患者的影响:一项日本全国性研究
Antibiotics (Basel). 2024 Dec 5;13(12):1182. doi: 10.3390/antibiotics13121182.
4
Necrotizing Pneumonia: A Practical Guide for the Clinician.坏死性肺炎:临床医生实用指南
Pathogens. 2024 Nov 10;13(11):984. doi: 10.3390/pathogens13110984.
5
A targeted likelihood estimation comparing cefepime and piperacillin/tazobactam in critically ill patients with community-acquired pneumonia (CAP).一项针对社区获得性肺炎(CAP)危重症患者中头孢吡肟和哌拉西林/他唑巴坦的靶向似然比估计的比较。
Sci Rep. 2024 Jun 11;14(1):13392. doi: 10.1038/s41598-024-64444-3.
6
A score to predict Pseudomonas aeruginosa infection in older patients with community-acquired pneumonia.预测老年社区获得性肺炎患者中铜绿假单胞菌感染的评分。
BMC Infect Dis. 2023 Oct 19;23(1):700. doi: 10.1186/s12879-023-08688-w.
7
Aetiological agents of adult community-acquired pneumonia in Japan: systematic review and meta-analysis of published data.日本成人社区获得性肺炎的病原体:已发表数据的系统评价与荟萃分析
BMJ Open Respir Res. 2023 Sep;10(1). doi: 10.1136/bmjresp-2023-001800.
8
Synthesis and Biological Evaluation of Novel Pyrimidine Amine Derivatives Bearing Bicyclic Monoterpene Moieties.具有双环单萜部分的新型嘧啶胺衍生物的合成与生物评价。
Molecules. 2022 Nov 21;27(22):8104. doi: 10.3390/molecules27228104.